Rat and human fatty acid amide hydrolases: Overt similarities and hidden differences

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 11, 2012, Pages 1425-1433

  Di Venere, Almerinda ^a,b   Dainese, Enrico ^c,d   Fezza, Filomena ^b   Angelucci, Beatrice Clotilde ^c   Rosato, Nicola ^a,b   Cravatt, Benjamin F ^f   Finazzi Agrò, Alessandro ^b,e   Mei, Giampiero ^a,b   MacCarrone, Mauro ^c,d  

^a IRCCS NEUROMED   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF TERAMO   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Anandamide hydrolase; Endocannabinoid; Fluorescence; Membrane binding; Protein aggregation and stability

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; FATTY ACID AMIDASE; MEMBRANE PROTEIN; METHOXYARACHIDONYL FLUOROPHOSPHONATE; OLEAMIDE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; ENZYME ASSAY; ENZYME KINETICS; ENZYME STRUCTURE; FLUORESCENCE SPECTROSCOPY; HUMAN; LIGHT SCATTERING; LIPID BILAYER; MEASUREMENT; MEMBRANE BINDING; METABOLISM; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEQUENCE HOMOLOGY; TEMPERATURE DEPENDENCE;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; ENZYME INHIBITORS; FATTY ACIDS; HUMANS; KINETICS; PHOSPHONIC ACIDS; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; RATS; SUBSTRATE SPECIFICITY;

ANIMALIA; RATTUS;

EID: 84865302914     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.07.021     Document Type: Article

References (65)

1. A.C. Howlett, L.C. Blume, and G.D. Dalton CB(1) cannabinoid receptors and their associated proteins Curr. Med. Chem. 17 2010 1382 1393
2. V. Di Marzo Endocannabinoids: synthesis and degradation Rev. Physiol. Biochem. Pharmacol. 160 2008 1 24
3. V. Di Marzo, and L. De Petrocellis Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs Curr. Med. Chem. 17 2010 1430 1449
4. M. Pistis, and M. Melis From surface to nuclear receptors: the endocannabinoid family extends its assets Curr. Med. Chem. 17 2010 1450 1467
5. D.M. Lambert, S. Vandevoorde, G. Diependaele, S.J. Govaerts, and A.R. Robert Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice Epilepsia 42 2001 321 327
6. C. Thabuis, F. Destaillats, J.F. Landrier, D. Tissot-Favre, and J.C. Martin Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice Nutr. Biochem. 21 2010 922 928
7. M. Maccarrone, R. Pauselli, M. Di Rienzo, and A. Finazzi-Agrò Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells Biochem. J. 366 2002 137 144
8. E. Murillo-Rodriguez, F. Desarnaud, and O. Prospero-Garcia Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat Life Sci. 79 2006 30 37
9. D. Piomelli The molecular logic of endocannabinoid signalling Nat. Rev. Neurosci. 4 2003 873 884
10. M. Maccarrone, E. Dainese, and S. Oddi Intracellular trafficking of anandamide: new concepts for signaling Trends Biochem. Sci. 35 2010 601 608
11. I. Katona, and T.F. Freund Endocannabinoid signaling as a synaptic circuit breaker in neurological disease Nat. Med. 14 2008 923 930
12. C. Pagano, M. Rossato, and R. Vettor Endocannabinoids, adipose tissue and lipid metabolism J. Neuroendocrinol. 1 2008 124 129
13. M. Maccarrone Endocannabinoids: friends and foes of reproduction Prog. Lipid Res. 48 2009 344 354
14. P. Pacher, and S. Steffens The emerging role of the endocannabinoid system in cardiovascular disease Semin. Immunopathol. 31 2009 63 77
15. S. Petrosino, A. Ligresti, and V. Di Marzo Endocannabinoid chemical biology: a tool for the development of novel therapy Curr. Opin. Chem. Biol. 13 2009 309 320
16. L.K. Miller, and L.A. Devi The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications Pharmacol. Rev. 63 2011 461 740
17. B.F. Cravatt, K. Demarest, M.P. Patricelli, M.H. Bracey, D.K. Giang, B.R. Martin, and A.H. Lichtman Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc. Natl. Acad. Sci. U. S. A. 98 2001 9371 9376
18. J.Z. Long, M. La Cava, X. Jin, and B.F. Cravatt An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase J. Lipid Res. 52 2011 337 344
19. D. Centonze, A. Finazzi-Agrò, G. Bernardi, and M. Maccarrone The endocannabinoid system in targeting inflammatory neurodegenerative diseases Trends Pharmacol. Sci. 28 2007 180 187
20. S. Kathuria, S. Gaetani, D. Fegley, F. Valino, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G. La Rana, A. Calignano, A. Giustino, M. Tattoli, M. Palmery, V. Cuomo, and D. Piomelli Modulation of anxiety through blockade of anandamide hydrolysis Nat. Med. 9 2003 76 81
21. S. Patel, and C.J. Hillard Role of endocannabinoid signaling in anxiety and depression Curr. Top. Behav. Neurosci. 1 2009 347 371
22. R. Greco, V. Gasperi, M. Maccarrone, and C. Tassorelli The endocannabinoid system and migraine Exp. Neurol. 224 2010 85 91
23. S. Pillarisetti, C.W. Alexander, and I. Khanna Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases Drug Discov. Today 14 2009 1098 1111
24. M. Maccarrone Fatty acid amide hydrolase: a potential target for next generation therapeutics Curr. Pharm. Des. 12 2006 759 772
25. S.M. Saario, and J.T. Laitinen Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors Basic Clin. Pharmacol. Toxicol. 101 2007 287 293
26. M.H. Bracey, M.A. Hanson, K.R. Masuda, R.C. Stevens, and B.F. Cravatt Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling Science 298 2002 1793 1796
27. M.K. McKinney, and B.F. Cravatt Structure and function of fatty acid amide hydrolase Annu. Rev. Biochem. 74 2005 411 432
28. F. Fezza, C. De Simone, D. Amadio, and M. Maccarrone Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system Subcell. Biochem. 49 2008 101 132
29. M. Mileni, D.S. Johnson, Z. Wang, D.S. Everdeen, M. Liimatta, B. Pabst, K. Bhattacharya, R.A. Nugent, S. Kamtekar, B.F. Cravatt, K. Ahn, and R.C. Stevens Structure-guided inhibitor design for human FAAH by interspecies active site conversion Proc. Natl. Acad. Sci. U. S. A. 105 2008 12820 12824
30. X. Min, S.T. Thibault, A.C. Porter, D.J. Gustin, T.J. Carlson, H. Xu, M. Lindstrom, G. Xu, C. Uyeda, Z. Ma, Y. Li, F. Kayser, N.P. Walker, and Z. Wang Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase FAAH Proc. Natl. Acad. Sci. U. S. A. 108 2011 7379 7384
31. G. Mei, A. Di Venere, V. Gasperi, E. Nicolai, K.R. Masuda, A. Finazzi-Agrò, B.F. Cravatt, and M. Maccarrone Closing the gate to the active site: effect of the inhibitor methoxyarachidonyl fluorophosphonate on the conformation and membrane binding of fatty acid amide hydrolase J. Biol. Chem. 282 2007 3829 3836
32. M.P. Patricelli, H.A. Lashuel, D.K. Giang, J.W. Kelly, and B.F. Cravatt Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization Biochemistry 37 1998 15177 15187
33. J.T. Yang, C.S. Wu, and H.M. Martinez Calculation of protein conformation from circular dichroism Methods Enzymol. 130 1986 208 269
34. J.R. Lakowicz Principles of Fluorescence Spectroscopy 2nd ed. 1999 Kluwer Academic/Plenum Publishers New York
35. A.G. Szabo, and D.M. Rayner Fluorescence decay of tryptophan conformers in aqueous solution J. Am. Chem. Soc. 102 1980 554 563
36. N. Rosato, E. Gratton, G. Mei, and A. Finazzi-Agrò Fluorescence lifetime distributions in human superoxide dismutase. Effect of temperature and denaturation Biophys. J. 55 1990 817 822
37. E. Dainese, C.B. Angelucci, A. Sabatucci, V. De Filippis, G. Mei, and M. Maccarrone A novel role for iron in modulating the activity and membrane-binding ability of a trimmed soybean lipoxygenase-1 FASEB J. 24 2010 1725 1736
38. D.E. Saslowsky, J. Lawrence, X. Ren, D.A. Brown, R.M. Henderson, and J.M. Edwardson Placental alkaline phosphatase is efficiently targeted to rafts in supported lipid bilayers J. Biol. Chem. 277 2002 26966 26970
39. W.F. Bennett, J.L. MacCallum, M.J. Hinner, S.J. Marrink, and D.P. Tieleman Molecular view of cholesterol flip-flop and chemical potential in different membrane environments J. Am. Chem. Soc. 131 2009 12714 12720
40. D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, G. Tarzia, and D. Piomelli Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation J. Pharmacol. Exp. Ther. 313 2005 352 358
41. S. Gattinoni, C. De Simone, S. Dallavalle, F. Fezza, R. Nannei, D. Amadio, P. Minetti, G. Quattrociocchi, A. Caprioli, F. Borsini, W. Cabri, S. Penco, L. Merlini, and M. Maccarrone Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system ChemMedChem 5 2010 357 360
42. M. Mor, S. Rivara, A. Lodola, P.V. Plazzi, G. Tarzia, A. Duranti, A. Tontini, G. Piersanti, S. Kathuria, and D. Piomelli Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies J. Med. Chem. 47 2004 4998 5008
43. J.M. Keith, R. Apodaca, W. Xiao, M. Seierstad, K. Pattabiraman, J. Wu, M. Webb, M.J. Karbarz, S. Brown, S. Wilson, B. Scott, C.S. Tham, L. Luo, J. Palmer, M. Wennerholm, S. Chaplan, and J.G. Breitenbucher Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase Bioorg. Med. Chem. Lett. 18 2008 4838 4843
44. F.A. Romero, W. Du, I. Hwang, T.J. Rayl, F.S. Kimball, D. Leung, H.S. Hoover, R.L. Apodaca, J.G. Breitenbucher, B.F. Cravatt, and D.L. Boger Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase J. Med. Chem. 50 2007 1058 1068
45. E. Gasteiger, A. Gattiker, C. Hoogland, I. Ivanyi, R.D. Appel, and A. Bairoch ExPASy: the proteomics server for in-depth protein knowledge and analysis Nucleic Acids Res. 31 2003 3784 3788
46. S.Y. Venyaminov, and T. Yang Determination of protein secondary structure G.D. Fasman, Circular Dichroism and the Conformational Analysis of Biomolecules 1996 Plenum New York 69 107
47. S.Y. Venyaminov, I.A. Baikalov, Z.M. Shen, C.S. Wu, and J.T. Yang Circular dichroic analysis of denatured proteins: inclusion of denatured proteins in the reference set Anal. Biochem. 214 1993 17 24
48. G. Mei, A. Di Venere, E. Nicolai, C.B. Angelucci, I. Ivanov, A. Sabatucci, E. Dainese, H. Kuhn, and M. Maccarrone Structural properties of plant and mammalian lipoxygenases. Temperature-dependent conformational alterations and membrane binding ability Biochemistry 47 2008 9234 9242
49. J.F. Nagle, and S. Tristram-Nagle Structure of lipid bilayers Biochim. Biophys. Acta 1469 2000 159 195
50. B.J. Litman, E.N. Lewis, and I.W. Levin Packing characteristics of highly unsaturated bilayer lipids: Raman spectroscopic studies of multilamellar phosphatidylcholine dispersions Biochemistry 30 1991 313 319
51. L.J. Pike Lipid rafts: bringing order to chaos J. Lipid Res. 44 2003 655 667
52. E. Dainese, S. Oddi, M. Bari, and M. Maccarrone Modulation of the endocannabinoid system by lipid rafts Curr. Med. Chem. 14 2007 2702 2715
53. S. Petrosino, and V. Di Marzo FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels Curr. Opin. Investig. Drugs 11 2010 51 62
54. A. Lodola, S. Rivara, and M. Mor Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure Adv. Protein Chem. Struct. Biol. 85 2011 1 26
55. K. Otrubova, C. Ezzili, and D.L. Boger The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH) Bioorg. Med. Chem. Lett. 21 2011 4674 4685
56. G. Mei, L. Pugliese, N. Rosato, L. Toma, M. Bolognesi, and A. Finazzi-Agrò Biotin and biotin analogues specifically modify the fluorescence decay of avidin J. Mol. Biol. Chem. 242 1994 559 565
57. A. Di Venere, M.L. Salucci, G. van Zadelhoff, G. Veldink, G. Mei, N. Rosato, A. Finazzi-Agrò, and M. Maccarrone Structure-to-function relationship of mini-lipoxygenase, a 60-kDa fragment of soybean lipoxygenase-1 with lower stability but higher enzymatic activity J. Biol. Chem. 278 2003 18281 18288
58. T. Hart, A.T. Macias, K. Benwell, T. Brooks, J. D'Alessandro, P. Dokurno, G. Francis, B. Gibbons, T. Haymes, G. Kennett, S. Lightowler, H. Mansell, N. Matassova, A. Misra, A. Padfield, R. Parsons, R. Pratt, A. Robertson, S. Walls, M. Wong, and S. Roughley Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas Bioorg. Med. Chem. Lett. 19 2009 4241 4244
59. S.D. Roughley, H. Browne, A.T. Macias, K. Benwell, T. Brooks, J. D'Alessandro, Z. Daniels, S. Dugdale, G. Francis, B. Gibbons, T. Hart, T. Haymes, G. Kennett, S. Lightowler, N. Matassova, H. Mansell, A. Merrett, A. Misra, A. Padfield, R. Parsons, R. Pratt, A. Robertson, H. Simmonite, K. Tan, S.B. Walls, and M. Wong Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity Bioorg. Med. Chem. Lett. 22 2012 901 906
60. K. Ahn, D.S. Johnson, M. Mileni, D. Beidler, J.Z. Long, M.K. McKinney, E. Weerapana, N. Sadagopan, M. Liimatta, S.E. Smith, S. Lazerwith, C. Stiff, S. Kamtekar, K. Bhattacharya, Y. Zhang, S. Swaney, K. Van Becelaere, R.C. Stevens, and B.F. Cravatt Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain Chem. Biol. 16 2009 411 420
61. C. Ezzili, M. Mileni, N. McGlinchey, J.Z. Long, S.G. Kinsey, D.G. Hochstatter, R.C. Stevens, A.H. Lichtman, B.F. Cravatt, E.J. Bilsky, and D.L. Boger Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics J. Med. Chem. 54 2011 2805 2822
62. S. Oddi, F. Fezza, N. Pasquariello, C. De Simone, C. Rapino, E. Dainese, A. Finazzi-Agrò, and M. Maccarrone Evidence for the intracellular accumulation of anandamide in adiposomes Cell. Mol. Life Sci. 65 2008 840 850
63. E. Dainese, S. Oddi, and M. Maccarrone Interaction of endocannabinoid receptors with biological membranes Curr. Med. Chem. 17 2010 1487 1499
64. B.Q. Wei, T.S. Mikkelsen, M.K. McKinney, E.S. Lander, and B.F. Cravatt A second fatty acid amide hydrolase with variable distribution among placental mammals J. Biol. Chem. 281 2006 36569 36578
65. M. Maccarrone, G. Bernardi, A. Finazzi-Agrò, and D. Centonze Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance Br. J. Pharmacol. 163 2011 1379 1390